Morphochem Aktiengesellschaft für kombinatorische Chemie
发明人:
申请号：
EP19157832.7
公开号：
EP3517106A1
申请日:
2014.05.09
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
